{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:53:11Z","timestamp":1785358391816,"version":"3.55.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.mcna.2022.12.001","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T12:29:00Z","timestamp":1676896140000},"page":"397-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Past, Present, and Future of Noninvasive Test in Chronic Liver Diseases"],"prefix":"10.1016","volume":"107","author":[{"given":"Douglas","family":"Chee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Han","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai En","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Q.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9724-4743","authenticated-orcid":false,"given":"Mark","family":"Muthiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.mcna.2022.12.001_bib1","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","article-title":"Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis","volume":"18","author":"Moon","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Sepanlou","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.mcna.2022.12.001_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.mcna.2022.12.001_bib4","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease","volume":"65","author":"Fazel","year":"2016","journal-title":"Metabolism"},{"issue":"0","key":"10.1016\/j.mcna.2022.12.001_bib5","article-title":"Mortality Outcomes by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis","volume":"0","author":"Ng","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.001_bib6","first-page":"1334","article-title":"The long-term pathological evolution of chronic hepatitis C","volume":"23","author":"Yano","year":"1996","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jhep.2016.11.011","article-title":"Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease","volume":"66","author":"Lackner","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.mcna.2022.12.001_bib8","article-title":"Fibrosis Stage-specific Incidence of Hepatocellular Cancer After Hepatitis C Cure With Direct-acting Antivirals: A Systematic Review and Meta-analysis","author":"Kim","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.001_bib9","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling Variability of Liver Fibrosis in Chronic Hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.001_bib10","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jhep.2020.06.025","article-title":"Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials","volume":"73","author":"Davison","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.001_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gtc.2019.09.007","article-title":"Burden of Disease due to Nonalcoholic Fatty Liver Disease","volume":"49","author":"Muthiah","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"issue":"9","key":"10.1016\/j.mcna.2022.12.001_bib12","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/apt.16595","article-title":"Systematic review with meta-analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B","volume":"54","author":"Zheng","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2022.12.001_bib13","doi-asserted-by":"crossref","first-page":"gov040","DOI":"10.1093\/gastro\/gov040","article-title":"Steatosis and hepatitis C","author":"Modaresi Esfeh","year":"2015","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.001_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.2005.069757","article-title":"Steatosis in chronic hepatitis C: Why does it really matter?","volume":"55","author":"Asselah","year":"2006","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.mcna.2022.12.001_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101491","article-title":"The impact of steatosis on chronic hepatitis c progression and response to antiviral treatments","volume":"9","author":"Siphepho","year":"2021","journal-title":"Biomedicines"},{"issue":"42","key":"10.1016\/j.mcna.2022.12.001_bib16","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.3748\/wjg.v12.i42.6756","article-title":"Mechanisms and significance of liver steatosis in hepatitis C virus infection","volume":"12","author":"Negro","year":"2006","journal-title":"World J Gastroenterol : WJG"},{"key":"10.1016\/j.mcna.2022.12.001_bib17","article-title":"Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis","author":"Israelsen","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2022.12.001_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: A simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"10.1016\/j.mcna.2022.12.001_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.mcna.2022.12.001_bib21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"Fedchuk","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.1840120505","article-title":"Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors","volume":"12","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ymgme.2021.01.007","article-title":"US-FLI score \u2013 Is it possible to predict the steatosis grade with an ultrasonographic score?","volume":"132","author":"Xavier","year":"2021","journal-title":"Mol Genet Metab"},{"issue":"8","key":"10.1016\/j.mcna.2022.12.001_bib24","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1478-3231.2012.02804.x","article-title":"Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD","volume":"32","author":"Ballestri","year":"2012","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.001_bib25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.14366\/usg.21150","article-title":"Noninvasive assessment of hepatic steatosis using a pathologic reference standard: comparison of CT, MRI, and US-based techniques","volume":"41","author":"Bae","year":"2021","journal-title":"Ultrasonography"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.001_bib26","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/hep.28699","article-title":"Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"64","author":"Hannah","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.mcna.2022.12.001_bib27","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3748\/wjg.14.1415","article-title":"Fatty liver disease in severe obese patients: Diagnostic value of abdominal ultrasound","volume":"14","author":"de Moura Almeida","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.mcna.2022.12.001_bib28","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/liv.12840","article-title":"Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients","volume":"35","author":"Bril","year":"2015","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.001_bib29","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2214\/AJR.07.2123","article-title":"Interobserver and intraobserver variability in the sonographic assessment of fatty liver","volume":"189","author":"Strauss","year":"2007","journal-title":"Am J Roentgenol"},{"issue":"12","key":"10.1016\/j.mcna.2022.12.001_bib30","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","article-title":"The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation","volume":"102","author":"Hamaguchi","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.001_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/s13244-021-01071-w","article-title":"Quantitative ultrasound imaging of soft biological tissues: a primer for radiologists and medical physicists","volume":"12","author":"Cloutier","year":"2021","journal-title":"Insights Imaging"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.001_bib32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/liv.15064","article-title":"A\u00a0novel quantitative ultrasound technique for identifying non-alcoholic steatohepatitis","volume":"42","author":"Gao","year":"2022","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib33","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib34","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s12072-014-9573-1","article-title":"Interobserver reproducibility of the controlled attenuation parameter (CAP) for quantifying liver steatosis","volume":"8","author":"Ferraioli","year":"2014","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jhep.2017.05.005","article-title":"Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter","volume":"67","author":"Wong","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.001_bib36","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib37","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00535-019-01635-0","article-title":"Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan\u00ae M\/XL probes to diagnose liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease: a multicenter prospective study","volume":"55","author":"Oeda","year":"2020","journal-title":"J\u00a0Gastroenterol"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S2468-1253(20)30357-5","article-title":"Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis","volume":"6","author":"Petroff","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib39","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.29639","article-title":"Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis","volume":"67","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.mcna.2022.12.001_bib40","doi-asserted-by":"crossref","first-page":"e13013","DOI":"10.1111\/ctr.13013","article-title":"Accuracy of computed tomography for detecting hepatic steatosis in donors for liver transplantation: A meta-analysis","volume":"31","author":"Zheng","year":"2017","journal-title":"Clin Transpl"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.001_bib41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1148\/radiol.2391050361","article-title":"Macrovesicular Hepatic Steatosis in Living Liver Donors: Use of CT for Quantitative and Qualitative Assessment1","volume":"239","author":"Park","year":"2006","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.001_bib42","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1148\/radiol.2301021176","article-title":"Macrovesicular Hepatic Steatosis in Living Related Liver Donors: Correlation between CT and Histologic Findings1","volume":"230","author":"Limanond","year":"2004","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.mcna.2022.12.001_bib43","doi-asserted-by":"crossref","first-page":"e110964","DOI":"10.1371\/journal.pone.0110964","article-title":"Separation of Hepatic Iron and Fat by Dual-Source Dual-Energy Computed Tomography Based on Material Decomposition: An Animal Study","volume":"9","author":"Ma","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.001_bib44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/RLI.0b013e31820e1486","article-title":"Quantification of liver fat in the presence of iron and iodine: An ex-vivo dual-energy CT study","volume":"46","author":"Fischer","year":"2011","journal-title":"Invest Radiol"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.001_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1148\/radiol.10091790","article-title":"Assessment of Hepatic Steatosis in Patients Undergoing Liver Resection: Comparison of US, CT, T1-weighted Dual-Echo MR Imaging, and Point-resolved 1H MR Spectroscopy1","volume":"256","author":"van Werven","year":"2010","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.001_bib46","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1148\/radiol.14140754","article-title":"Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease","volume":"274","author":"Tang","year":"2015","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","article-title":"Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease","volume":"152","author":"Park","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib48","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/hep.28012","article-title":"Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex\u00a0vivo human livers","volume":"62","author":"Bannas","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.001_bib49","first-page":"1334","article-title":"The Long-Term Pathological Evolution of Chronic Hepatitis C","volume":"23","author":"Yano","year":"1996","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.001_bib50","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","article-title":"Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality","volume":"53","author":"Younossi","year":"2011","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.mcna.2022.12.001_bib51","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple noninvasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.mcna.2022.12.001_bib52","first-page":"1682","article-title":"Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis","volume":"103","author":"Wong","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.001_bib53","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib54","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib55","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a Confounding Factor for the Accurate Noninvasive Diagnosis of Advanced NAFLD Fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib56","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2021-324243","article-title":"Diagnostic accuracy of noninvasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis","volume":"71","author":"M\u00f3zes","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.mcna.2022.12.001_bib57","article-title":"Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population","author":"Graupera","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib58","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10238-015-0388-8","article-title":"Hyaluronic acid concentration in liver diseases","volume":"16","author":"Gudowska","year":"2016","journal-title":"Clin Exp Med"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib59","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1478-3231.2005.01064.x","article-title":"Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease","volume":"25","author":"Suzuki","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.mcna.2022.12.001_bib60","article-title":"Diagnostic Value of Serum Procollagen III N-Terminal Peptide for Liver Fibrosis in Infantile Cholestasis","volume":"8","author":"Wang","year":"2020","journal-title":"Front Pediatr"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib61","first-page":"303","article-title":"The Neo-Epitope Specific PRO-C3 ELISA Measures True Formation of Type III Collagen Associated with Liver and Muscle Parameters","volume":"5","author":"Nielsen","year":"2013","journal-title":"Am J Transl Res"},{"issue":"12","key":"10.1016\/j.mcna.2022.12.001_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9121920","article-title":"Systematic review with meta-analysis: Diagnostic accuracy of pro-c3 for hepatic fibrosis in patients with non-alcoholic fatty liver disease","volume":"9","author":"Mak","year":"2021","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib63","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","article-title":"Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies","volume":"46","author":"Hemmann","year":"2007","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib64","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000439083","article-title":"Tissue inhibitors of metalloproteinase-1 and 2 and obesity related non-alcoholic fatty liver disease: Is there a relationship?","volume":"92","author":"Abdelaziz","year":"2015","journal-title":"Digestion"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.001_bib65","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2020.03.036","article-title":"Enhanced liver fibrosis test for the noninvasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis","volume":"73","author":"Vali","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.001_bib66","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jhep.2013.03.016","article-title":"The Enhanced Liver Fibrosis (ELF) score: Normal values, influence factors and proposed cut-off values","volume":"59","author":"Lichtinghagen","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.mcna.2022.12.001_bib67","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.23923","article-title":"Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis among Patients with Nonalcoholic Fatty Liver Disease","volume":"4","author":"Younossi","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9262","key":"10.1016\/j.mcna.2022.12.001_bib68","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2022.12.001_bib69","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-6-6","article-title":"Diagnostic value of biochemical markers (Fibro Test-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Ratziu","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"10.1016\/j.mcna.2022.12.001_bib70","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/apt.13770","article-title":"Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference","volume":"44","author":"Munteanu","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.mcna.2022.12.001_bib71","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/jgh.13671","article-title":"Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease","volume":"32","author":"Loong","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol (Australia)"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib72","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/hep.30163","article-title":"ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis","volume":"69","author":"Daniels","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib73","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jhepr.2019.06.004","article-title":"Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease","volume":"1","author":"Boyle","year":"2019","journal-title":"JHEP Rep"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib74","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2020.11.050","article-title":"Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease","volume":"74","author":"Papatheodoridi","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.mcna.2022.12.001_bib75","first-page":"100596","article-title":"Real-world evidence on noninvasive tests and associated cut-offs used to assess fibrosis in routine clinical practice","volume":"22","author":"Lazarus","year":"2022","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2012.09.025","article-title":"Association Between Anthropometric Parameters and Measurements of Liver Stiffness by Transient Elastography","volume":"11","author":"Wong","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib77","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hep.23425","article-title":"Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations","volume":"51","author":"Castera","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.001_bib78","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.28394","article-title":"Liver Stiffness in Nonalcoholic Fatty Liver Disease: A Comparison of Supersonic Shear Imaging, FibroScan, and ARFI With Liver Biopsy a he study of liver diseases t american association for","volume":"63","author":"Cassinotto","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib79","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ultrasmedbio.2020.11.013","article-title":"Comparison of 2-D Shear Wave Elastography and Point Shear Wave Elastography for Assessing Liver Fibrosis","volume":"47","author":"Zhou","year":"2021","journal-title":"Ultrasound Med Biol"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib80","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","article-title":"Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease Than Transient Elastography","volume":"150","author":"Imajo","year":"2016","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.mcna.2022.12.001_bib81","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.cgh.2017.10.037","article-title":"Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease","volume":"16","author":"Caussy","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.mcna.2022.12.001_bib82","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in noninvasive assessment of hepatic fibrosis","volume":"69","author":"Loomba","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib83","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.cgh.2020.12.016","article-title":"Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease","volume":"20","author":"Imajo","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib84","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cgh.2018.05.059","article-title":"Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants","volume":"17","author":"Hsu","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib85","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.001_bib86","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/hep.32151","article-title":"Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: A retrospective study","volume":"75","author":"Gidener","year":"2022","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.mcna.2022.12.001_bib87","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/jgh.14298","article-title":"Magnetic resonance elastography increases usefulness and safety of noninvasive screening for esophageal varices","volume":"33","author":"Matsui","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.mcna.2022.12.001_bib88","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/hepr.13533","article-title":"Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis","volume":"50","author":"Tamaki","year":"2020","journal-title":"Hepatol Res"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib89","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/hep.28390","article-title":"Noninvasive fatty liver markers predict liver disease mortality in the U.S. population","volume":"63","author":"Unalp-Arida","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib90","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/liv.14301","article-title":"Liver stiffness measurement predicts long-term survival and complications in non-alcoholic fatty liver disease","volume":"40","author":"Shili-Masmoudi","year":"2020","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib91","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.cgh.2021.07.021","article-title":"Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease","volume":"20","author":"Tamaki","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib92","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/apt.16745","article-title":"Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality","volume":"55","author":"Higuchi","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.001_bib93","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/hep.31608","article-title":"Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study","volume":"73","author":"Long","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095776","article-title":"Liver Stiffness by Transient Elastography Predicts Liver-Related Complications and Mortality in Patients with Chronic Liver Disease","volume":"9","author":"Pang","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.001_bib95","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-021-01388-2","article-title":"Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study","volume":"20","author":"Cardoso","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.001_bib96","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.gastro.2019.09.008","article-title":"Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease","volume":"158","author":"Hagstr\u00f6m","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.001_bib97","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.dld.2020.10.014","article-title":"Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population","volume":"53","author":"Schonmann","year":"2021","journal-title":"Dig Liver Dis"},{"issue":"0","key":"10.1016\/j.mcna.2022.12.001_bib98","article-title":"The Fibrosis-4 (FIB-4) Index Predicts Cardiovascular Major Adverse Events and Mortality in Patients with Non-alcoholic Fatty Liver Disease","volume":"0","author":"Chew","year":"2022","journal-title":"Can J Cardiol"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.001_bib99","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.clinre.2017.03.010","article-title":"The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort study","volume":"41","author":"Jaruvongvanich","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib100","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2013.06.057","article-title":"Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease","volume":"145","author":"Angulo","year":"2013","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.mcna.2022.12.001_bib101","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/gut.2009.203166","article-title":"Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease","volume":"59","author":"Parkes","year":"2010","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib102","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension","volume":"63","author":"Kamath","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib103","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII \u2013 Renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.001_bib104","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2012.11.015","article-title":"When the spleen gets tough, the varices get going","volume":"144","author":"Cast\u00e9ra","year":"2013","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib105","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3350\/cmh.2013.19.4.370","article-title":"The usefulness of noninvasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data","volume":"19","author":"Hong","year":"2013","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib106","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/hep4.1855","article-title":"The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis","volume":"6","author":"Reiberger","year":"2022","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib107","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on noninvasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.mcna.2022.12.001_bib108","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.cgh.2019.04.062","article-title":"Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis","volume":"17","author":"Stafylidou","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"AUG","key":"10.1016\/j.mcna.2022.12.001_bib109","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3389\/fphys.2019.01028","article-title":"Baveno criteria safely identify patients with compensated advanced chronic liver disease who can avoid variceal screening endoscopy: A diagnostic test accuracy meta-analysis","volume":"10","author":"Szak\u00e1cs","year":"2019","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.001_bib110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ultrasmedbio.2016.07.025","article-title":"A\u00a0Meta-analysis for the Diagnostic Performance of Transient Elastography for Clinically Significant Portal Hypertension","volume":"43","author":"You","year":"2017","journal-title":"Ultrasound Med Biol"},{"issue":"7","key":"10.1016\/j.mcna.2022.12.001_bib111","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1007\/s10620-021-07277-8","article-title":"Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography","volume":"67","author":"Podrug","year":"2022","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib112","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib113","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.mcna.2022.12.001_bib114","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jceh.2021.10.128","article-title":"AGILE 3+ Score for Assessing Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) \u2013 Validation in an Indian Cohort","volume":"12","author":"De","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.mcna.2022.12.001_bib115","article-title":"AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD","author":"Pennisi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib116","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the noninvasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib117","doi-asserted-by":"crossref","first-page":"e0266859","DOI":"10.1371\/journal.pone.0266859","article-title":"Validation of the accuracy of the FASTTM score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other noninvasive algorithms","volume":"17","author":"Woreta","year":"2022","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib118","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jhep.2021.11.012","article-title":"MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis","volume":"76","author":"Noureddin","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.mcna.2022.12.001_bib119","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1136\/gutjnl-2020-322976","article-title":"MRE combined with FIB-4 (MEFIB) Index in detection of candidates for pharmacologic treatment of NASH related fibrosis","volume":"70","author":"Jung","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.mcna.2022.12.001_bib120","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2022.06.073","article-title":"Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants","author":"Ajmera","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2022.12.001_bib121","article-title":"Head to head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD","volume":"13","author":"Kim","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.mcna.2022.12.001_bib122","doi-asserted-by":"crossref","DOI":"10.14309\/ajg.0000000000001906","article-title":"Combining FIB-4 and liver stiffness into the FIB-5, a single model that accurately predicts complications of portal hypertension","author":"Vutien","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib123","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.001_bib124","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31060","article-title":"Hepatitis C Guidance 2019\u00a0Update: American Association for the Study of Liver Diseases\u2013Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection","volume":"71","author":"Ghany","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib125","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: Final update of the series","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.001_bib126","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.001_bib127","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2020.10.016","article-title":"HCC surveillance after SVR in patients with F3\/F4 fibrosis","volume":"74","author":"Ioannou","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"10179","key":"10.1016\/j.mcna.2022.12.001_bib128","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","article-title":"Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study","volume":"393","author":"Carrat","year":"2019","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.001_bib129","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2021.09.013","article-title":"Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR","volume":"76","author":"D\u2019Ambrosio","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.001_bib130","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.25606","article-title":"A\u00a0morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis","volume":"56","author":"D\u2019Ambrosio","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.001_bib131","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/hep.31462","article-title":"Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease","volume":"73","author":"Semmler","year":"2021","journal-title":"Hepatology"},{"issue":"0","key":"10.1016\/j.mcna.2022.12.001_bib132","article-title":"Noninvasive tests for clinically significant portal hypertension after HCV cure","volume":"0","author":"Semmler","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib133","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.001_bib134","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/j.gastro.2021.10.051","article-title":"Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis","volume":"162","author":"Loomba","year":"2022","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.mcna.2022.12.001_bib137","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/apt.16596","article-title":"Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator-activated receptor \u03b1 modulator (SPPARM\u03b1), versus placebo in patients with non-alcoholic fatty liver disease","volume":"54","author":"Nakajima","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.mcna.2022.12.001_bib138","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/apt.16608","article-title":"Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging","volume":"54","author":"Flint","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.001_bib139","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/gutjnl-2021-324264","article-title":"Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease","volume":"71","author":"Tamaki","year":"2022","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.mcna.2022.12.001_bib140","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.cgh.2020.08.061","article-title":"Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis","volume":"19","author":"Stine","year":"2021","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712522001717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712522001717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:46:56Z","timestamp":1758419216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712522001717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":138,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0025712522001717"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2022.12.001","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Past, Present, and Future of Noninvasive Test in Chronic Liver Diseases","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2022.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}